Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.
The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.
Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.
Phone: 03 9265 5400
Navinci NaveniFlex Tissue Red proximity ligation assay kit
The kit enables fluorescence visualisation of protein–protein interactions or...
Bio-Rad Laboratories StarBright Dyes for spectral flow cytometry
The range provides users with more options when designing spectral flow cytometry panels,...
MaxWell Biosystems MaxOne+ HD-MEA Chip
The MaxOne+ HD-MEA Chip provides an upgraded performance and user experience through...
